Key result
Ultrasound-guided axillary venous access achieves ~89% lead implantation success in congenital patients without major complications.
Why the study?
Ultrasound-guided axillary venous access for pediatric transvenous lead implantation may reduce risks for pneumothorax and hemothorax, prompting evaluation of this technique as an alternative to the subclavian approach.
Is ultrasound-guided axillary venous access safe and efficacious for transvenous lead implantation in pediatric and adult congenital patients?
Observational (n=18)
Is ultrasound-guided axillary venous access safe and efficacious for transvenous lead implantation in pediatric and adult congenital patients?
Ultrasound-guided axillary venous access is a safe and feasible technique for transvenous lead implantation in pediatric and adult congenital patients, offering a low-risk alternative to the subclavian approach.
May support axillary access as low-risk alternative; hypothesis-generating in small cohort and requires larger comparative trials.
Background Axillary venous access with ultrasound guidance for pediatric transvenous lead implantation may reduce risks for pneumothorax and hemothorax. The objective was to retrospectively evaluate ultrasound‐guided axillary vein access as an alternative to the subclavian approach. Methods The technique consists of ultrasonographic identification of the axillary vein at the deltopectoral groove after initial contrast venography. A micropuncture kit is used for initial ultrasound‐guided percutaneous access with fluoroscopic confirmation of wire position. Pocket creation is performed, and sheath insertion and lead implantation proceed as usual. Demographic, procedural, and radiation exposure data were collected and analyzed. Results Sixteen patients (median age = 13 years, 8‐50 years; median weight = 56 kg, 29‐77 kg) underwent lead implantation; two additional patients required fluoroscopy due to poor acoustic windows (89% success). Fifteen of 21 leads (71%) were ventricular; 50% of implants were pacemakers, and 31% were dual chamber. Median time to venous access was 13 min (interquartile range (IQR) = 9.25‐20.25) and median implant procedure time was 156 min (IQR = 112‐172). Median fluoroscopy time was 18.0 min (IQR = 11.9‐29.6), median air kerma was 9.0 mGy (IQR = 3.0‐28.5), and median dose‐area product was 30.2 Gy‐cm 2 (IQR = 16.1‐234.5). One patient required generator pocket revision 2 days postprocedure without lead dislodgement. There were no other complications encountered. Conclusions Transvenous pacemaker and implantable cardioverter‐defibrillator lead implantation in the pediatric and adult congenital population through ultrasound‐guided axillary venous access is safe and efficacious. This technique may provide a low‐risk alternative for vascular access for pediatric implantation procedures.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2018) conducted an observational in Pediatric and adult congenital heart disease requiring transvenous lead implantation (n=18). Ultrasound-guided axillary venous access was evaluated on Procedural success of ultrasound-guided access. Ultrasound-guided axillary venous access for transvenous lead implantation in pediatric and adult congenital patients achieved an 89% success rate with no major complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: